loadpatents
name:-0.0059218406677246
name:-0.017102003097534
name:-0.00044798851013184
TEVA GYOGYSZERGYAR ZARTKORUEN MUKODO RESZVENYTARSASAG Patent Filings

TEVA GYOGYSZERGYAR ZARTKORUEN MUKODO RESZVENYTARSASAG

Patent Applications and Registrations

Patent applications and USPTO patent grants for TEVA GYOGYSZERGYAR ZARTKORUEN MUKODO RESZVENYTARSASAG.The latest application filed is for "crystalline forms of fesoterodine fumarate and fesoterodine base".

Company Profile
0.13.5
  • TEVA GYOGYSZERGYAR ZARTKORUEN MUKODO RESZVENYTARSASAG - Debrecen HU
  • TEVA Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag - HU HU
  • Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag -
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Crystalline Forms Of Fesoterodine Fumarate And Fesoterodine Base
App 20120220655 - Kerekes; Peter
2012-08-30
Process for constructing strain having compactin hydroxylation ability
Grant 7,700,752 - Szabo , et al. April 20, 2
2010-04-20
Process for constructing strain having compactin hydroxylation ability
Grant 7,700,337 - Szabo , et al. April 20, 2
2010-04-20
Process for preparation of amorphous form of a drug
Grant 7,589,128 - Szabo , et al. September 15, 2
2009-09-15
Method for extracting a macrolide from biomatter
Grant 7,452,692 - Keri , et al. November 18, 2
2008-11-18
Aztreonam .beta. polymorph with very low residual solvent content
Grant 7,452,991 - Gyollai , et al. November 18, 2
2008-11-18
Mycophenolate mofetil impurity
Grant 7,358,247 - Molnar , et al. April 15, 2
2008-04-15
Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide(zalep- lon) and crystalline forms of zaleplon accessible with the process
Grant 7,348,429 - Feher , et al. March 25, 2
2008-03-25
1H-imidazo [4,5-c] quinolin-4-cyano and 1H-imidazo [4,5-c] quinolin-4-carboxamide intermediates
Grant 7,335,772 - Merli , et al. February 26, 2
2008-02-26
Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide (zaleplon) and crystalline forms of zaleplon accessible with the process
App 20070238739 - Feher; Erika ;   et al.
2007-10-11
Methods of preparing pimecrolimus
Grant 7,279,571 - Gyollai , et al. October 9, 2
2007-10-09
Forms of pravastatin sodium
Grant 7,262,218 - Keri , et al. August 28, 2
2007-08-28
Novel forms of pravastatin sodium
App 20070197633 - Keri; Vilmos ;   et al.
2007-08-23
Method of purifying macrolides
App 20070117976 - Keri; Vilmos ;   et al.
2007-05-24
Preparation of 1H-imidazo [4,5-C] quinolin-4-amines via 1H-imidazo [4,5-C] quinolin-4-phthalimide intermediates
App 20070060755 - Merli; Valeriano ;   et al.
2007-03-15
Preparation of 1H-imidazo [4,5-C] quinolin-4-amines via 1H-imidazo [4,5-C] quinolin-4-phthalimide intermediates
Grant 7,153,967 - Merli , et al. December 26, 2
2006-12-26
Process for preparing and isolating rac-bicalutamide and its intermediates
Grant 7,102,026 - Dolitzky , et al. September 5, 2
2006-09-05
Process for the preparation of pseudomonic acid a antibiotic by microbiological method
Grant 7,078,223 - Szell , et al. July 18, 2
2006-07-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed